ATE451461T1 - Antigene polypeptide aus neisseria meningitidis, dafür kodierende polynukleotide und entsprechende schützende antikörper - Google Patents

Antigene polypeptide aus neisseria meningitidis, dafür kodierende polynukleotide und entsprechende schützende antikörper

Info

Publication number
ATE451461T1
ATE451461T1 AT00909329T AT00909329T ATE451461T1 AT E451461 T1 ATE451461 T1 AT E451461T1 AT 00909329 T AT00909329 T AT 00909329T AT 00909329 T AT00909329 T AT 00909329T AT E451461 T1 ATE451461 T1 AT E451461T1
Authority
AT
Austria
Prior art keywords
neisseria meningitidis
corresponding protective
protective antibodies
coding therefor
polynucleotides coding
Prior art date
Application number
AT00909329T
Other languages
English (en)
Inventor
Catherine Defrenne
Christine Delmelle
Jean-Louis Ruelle
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9905815.8A external-priority patent/GB9905815D0/en
Priority claimed from GBGB9909094.6A external-priority patent/GB9909094D0/en
Priority claimed from GBGB9909503.6A external-priority patent/GB9909503D0/en
Priority claimed from GBGB9909787.5A external-priority patent/GB9909787D0/en
Priority claimed from GBGB9910710.4A external-priority patent/GB9910710D0/en
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Application granted granted Critical
Publication of ATE451461T1 publication Critical patent/ATE451461T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT00909329T 1999-03-12 2000-03-07 Antigene polypeptide aus neisseria meningitidis, dafür kodierende polynukleotide und entsprechende schützende antikörper ATE451461T1 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GBGB9905815.8A GB9905815D0 (en) 1999-03-12 1999-03-12 Novel compounds
GBGB9909094.6A GB9909094D0 (en) 1999-04-21 1999-04-21 Novel compounds
GBGB9909503.6A GB9909503D0 (en) 1999-04-23 1999-04-23 Novel compounds
GBGB9909787.5A GB9909787D0 (en) 1999-04-28 1999-04-28 Novel compounds
GBGB9910710.4A GB9910710D0 (en) 1999-05-07 1999-05-07 Novel compounds
PCT/EP2000/001955 WO2000055327A2 (en) 1999-03-12 2000-03-07 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies

Publications (1)

Publication Number Publication Date
ATE451461T1 true ATE451461T1 (de) 2009-12-15

Family

ID=27517501

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00909329T ATE451461T1 (de) 1999-03-12 2000-03-07 Antigene polypeptide aus neisseria meningitidis, dafür kodierende polynukleotide und entsprechende schützende antikörper

Country Status (11)

Country Link
US (3) US7666988B1 (de)
EP (3) EP2163628A3 (de)
AT (1) ATE451461T1 (de)
AU (1) AU3164600A (de)
CA (1) CA2365102A1 (de)
CY (1) CY1109812T1 (de)
DE (1) DE60043499D1 (de)
DK (1) DK1163343T3 (de)
ES (1) ES2337650T3 (de)
PT (1) PT1163343E (de)
WO (1) WO2000055327A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9808866D0 (en) * 1998-04-24 1998-06-24 Smithkline Beecham Biolog Novel compounds
EP2261347A3 (de) * 1998-05-01 2012-01-11 Novartis Vaccines and Diagnostics, Inc. Antigene und Zusammensetzungen gegen Neisseria meningitidis
US7666988B1 (en) 1999-03-12 2010-02-23 Glaxosmithkline Biologicals S.A. BASB082 Polypeptides
US6798520B2 (en) 2002-03-22 2004-09-28 Diversa Corporation Method for intensifying the optical detection of samples that are held in solution in the through-hole wells of a holding tray
GB0816447D0 (en) 2008-09-08 2008-10-15 Glaxosmithkline Biolog Sa Vaccine
EP2544714A1 (de) 2010-03-10 2013-01-16 GlaxoSmithKline Biologicals S.A. Impfstoffzusammensetzung
BR112012022800A2 (pt) * 2010-03-11 2018-05-15 Glaxosmithkline Biologicals Sa composição imunogênica ou vacina, cepa bacteriana gram-negativa geneticamente engenheirada, métodos para o tratamento ou prevenção de infecção ou doença, para produzir uma composição imunogênica ou uma vacina, e para preparar uma imunoglobulina, preparação da imunoglobulina, e, preparação farmacêutica
MX2014008988A (es) 2012-02-02 2014-08-27 Novartis Ag Promotores para aumento de expresion de proteinas en meningococo.

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US121528A (en) 1871-12-05 Improvement in bridle-blinders for horses
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
GB9022190D0 (en) 1990-10-12 1990-11-28 Perham Richard N Immunogenic material
CA2138997C (en) 1992-06-25 2003-06-03 Jean-Paul Prieels Vaccine composition containing adjuvants
SG48309A1 (en) 1993-03-23 1998-04-17 Smithkline Beecham Biolog Vaccine compositions containing 3-0 deacylated monophosphoryl lipid a
WO1994022914A1 (en) 1993-04-06 1994-10-13 Fred Hutchinson Cancer Research Center Chimeric cytokine receptors in lymphocytes
AU683073B2 (en) 1993-06-07 1997-10-30 Amgen, Inc. Hybrid receptor molecules
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
WO1996002555A1 (en) 1994-07-15 1996-02-01 The University Of Iowa Research Foundation Immunomodulatory oligonucleotides
US6121037A (en) 1994-10-18 2000-09-19 Stojiljkovic; Igor Bacterial hemoglobin receptor genes
UA56132C2 (uk) 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
FR2751000B1 (fr) 1996-07-12 1998-10-30 Inst Nat Sante Rech Med Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
EP1900818A3 (de) * 1997-11-06 2008-06-11 Novartis Vaccines and Diagnostics S.r.l. Neissersche Antigene
US20070026021A1 (en) 1998-05-01 2007-02-01 Chiron S.R.I. Neisseria meningitidis antigens and compositions
EP2261347A3 (de) * 1998-05-01 2012-01-11 Novartis Vaccines and Diagnostics, Inc. Antigene und Zusammensetzungen gegen Neisseria meningitidis
MXPA01003557A (es) 1998-10-09 2004-04-05 Chiron Corp Secuencias genomicas de neisseria y metodos para su uso.
US7666988B1 (en) * 1999-03-12 2010-02-23 Glaxosmithkline Biologicals S.A. BASB082 Polypeptides
CA2371032A1 (en) 1999-04-30 2000-11-09 Chiron Corporation Neisseria genomic sequences and methods of their use
GB0011108D0 (en) 2000-05-08 2000-06-28 Microscience Ltd Virulence gene and protein and their use

Also Published As

Publication number Publication date
CY1109812T1 (el) 2014-09-10
DE60043499D1 (de) 2010-01-21
US20120328622A1 (en) 2012-12-27
US8580279B2 (en) 2013-11-12
EP2270169A2 (de) 2011-01-05
CA2365102A1 (en) 2000-09-21
EP2270169A3 (de) 2011-06-15
PT1163343E (pt) 2010-02-23
EP2163628A3 (de) 2010-06-02
WO2000055327A3 (en) 2001-01-04
US20100184139A1 (en) 2010-07-22
EP2163628A2 (de) 2010-03-17
US8217159B2 (en) 2012-07-10
AU3164600A (en) 2000-10-04
DK1163343T3 (da) 2010-04-19
EP1163343B1 (de) 2009-12-09
ES2337650T3 (es) 2010-04-28
US7666988B1 (en) 2010-02-23
EP1163343A2 (de) 2001-12-19
WO2000055327A2 (en) 2000-09-21

Similar Documents

Publication Publication Date Title
DK1078063T3 (da) BASB029-polynukleotider og -polypeptider fra Neisseria meningitidis
ATE312921T1 (de) Antigene polypeptide aus neisseria meningitidis, dafür kodierende polynukleotide und entsprechende schützende antikörper
DE60043499D1 (de) Antigene polypeptide aus neisseria meningitidis, dafür kodierende polynukleotide und entsprechende schützende antikörper
CY1108280T1 (el) Basb205 πολυπεπτιδια και πολυνουκλεοτιδια που τα κωδικοποιουν
ATE270332T1 (de) Polynucleotide and polypeptide basb033 aus neisseria meningitidis und ihre verwendungen
DE69928931D1 (de) Moraxella catarrhalis polynukleotide und polypeptide
DK1082435T3 (da) Proteiner og gener fra Moraxella catarrhalis, antigener, antistoffer og anvendelser
WO2000042191A3 (en) Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
ATE527360T1 (de) Neue verbindungen abgeleitet von neisseria meningitidis
DE60140006D1 (de) Polypeptide aus haemophilus influenza
HK1047943A1 (zh) 黏膜炎莫拉氏菌basb114抗原及其用途
ATE293693T1 (de) Moraxella catarrhalis antigen basb117
ATE399205T1 (de) Immunogene polypeptide aus moraxella catarrhalis und deren verwendungen
ATE515511T1 (de) Nicht-typisierbare haemophilus influenzae basb201 polypeptide und polynukleotide und deren verwendungen
DE60019613D1 (de) Moraxella catarrhalis antigen basb120
WO2002066503A3 (en) H. influenzae antigen basb213
ATE274582T1 (de) Basb028 polypeptiden und dafür kodierende polynukleotiden aus moraxella catarrhalis
DE60024456D1 (en) Basb111 polypeptid und polynukleotid aus moraxella catharralis
DE60035788D1 (de) Polypeptide aus moraxella (branhamella) catarrhalis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1163343

Country of ref document: EP